Advertisement
U.S. markets close in 34 minutes
  • S&P 500

    5,263.34
    +14.85 (+0.28%)
     
  • Dow 30

    39,855.75
    +95.67 (+0.24%)
     
  • Nasdaq

    16,406.57
    +7.04 (+0.04%)
     
  • Russell 2000

    2,124.15
    +9.80 (+0.46%)
     
  • Crude Oil

    83.08
    +1.73 (+2.13%)
     
  • Gold

    2,241.90
    +29.20 (+1.32%)
     
  • Silver

    24.97
    +0.22 (+0.88%)
     
  • EUR/USD

    1.0790
    -0.0040 (-0.37%)
     
  • 10-Yr Bond

    4.2060
    +0.0100 (+0.24%)
     
  • GBP/USD

    1.2622
    -0.0016 (-0.12%)
     
  • USD/JPY

    151.3950
    +0.1490 (+0.10%)
     
  • Bitcoin USD

    70,737.27
    +1,974.52 (+2.87%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,952.62
    +20.64 (+0.26%)
     
  • Nikkei 225

    40,168.07
    -594.66 (-1.46%)
     

Hospira beats profit estimates, raises 2014 outlook

July 30 (Reuters) - Hospira Inc, a pharmaceutical and medical device maker, posted a better-than-expected quarterly profit on higher sales of specialty injectable drugs, and raised its full-year outlook.

The company's net income more than doubled to $70.9 million, or 42 cents per share, for the second quarter ended June 30, from $32.9 million, or 20 cents per share, a year earlier.

Excluding items, it earned 72 cents per share. Revenue rose 10.7 percent to $1.14 billion, helped by a 13.8 percent increase in specialty injectable pharmaceuticals sales.

Analysts on average had expected earnings of 57 cents per share on revenue of $1.06 billion, according to Thomson Reuters I/B/E/S.

Hospira said it expects 2014 adjusted earnings of $2.30-$2.50 per share, up from its earlier adjusted earnings forecast of $2.00-$2.25 per share.

(Reporting by Anand Basu; Editing by Saumyadeb Chakrabarty)

Advertisement